摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-甲氧基-4-甲基苯基)乙酮 | 35633-35-3

中文名称
1-(2-甲氧基-4-甲基苯基)乙酮
中文别名
——
英文名称
2-methoxy-4-methylacetophenone
英文别名
1-(2-methoxy-4-methylphenyl)ethanone;2-Methoxy-4-methyl-acetophenon;1-(2-methoxy-4-methylphenyl)ethan-1-one
1-(2-甲氧基-4-甲基苯基)乙酮化学式
CAS
35633-35-3
化学式
C10H12O2
mdl
MFCD08239634
分子量
164.204
InChiKey
WZHJIIIJSONKDI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2914509090
  • 危险性防范说明:
    P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    存储条件:2-8℃,干燥环境中保存。

SDS

SDS:5c106beafea7e8289c26cecde61db632
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    1-(2-甲氧基-4-甲基苯基)乙酮 在 Porcine pancreas lipase type II 、 dimethyl sulfide borane对甲苯磺酸对苯二酚 作用下, 以 四氢呋喃乙醚甲基叔丁基醚 为溶剂, 反应 12.5h, 生成 (R)-2-(2-methoxy-4-methylphenyl)propan-1-ol
    参考文献:
    名称:
    Lipase-mediated resolution of substituted 2-aryl-propanols: application to the enantioselective synthesis of phenolic sesquiterpenes
    摘要:
    A comprehensive study of the lipase-mediated resolution of substituted 2-aryl-propanols is reported. The latter alcohols were submitted to the irreversible acetylation catalyzed either by PPL, CRL, or lipase PS. The enantioselectivity of these transformations was dependent on the type of lipase used. The type of substituents and particularly their position on the aromatic ring strongly affected the selectivity of the reaction. The experiments described prove that PPL is the more versatile lipase catalyzing the acetylation with an enantiomeric ratio (E) value that ranges from 1 up to 144, depending on the substrate used. Conversely, the same transformations were catalyzed by CRL and lipase PS with an enantiomeric ratio value, which is always less than 5. The remarkable behavior of PPL was exploited in the large scale resolution of some substituted 2-aryl-propanols whose enantiomeric forms are relevant building blocks in the enantioselective synthesis of phenolic sesquiterpenes. By these means, the synthesis of (S)-turmeronol B and the formal syntheses of (R)-curcumene, (R)-curcuphenol, (R)-xanthorrhizol, and (R)-curcuhydroquinone were accomplished. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2011.03.012
  • 作为产物:
    描述:
    乙酸间甲苯酯三氯化铝potassium carbonate 作用下, 以 二硫化碳丙酮 为溶剂, 反应 16.0h, 生成 1-(2-甲氧基-4-甲基苯基)乙酮
    参考文献:
    名称:
    Studies on Aromatic Sesquiterpenes. XI. Synthesis of 7-Isopropyl-3,5-dimethyl-1-naphthol
    摘要:
    从间甲酚出发,通过关键中间体4-甲基-3-(2-甲氧基-4-甲基苯甲酰基)戊酸,合成了新萘酚。
    DOI:
    10.1246/bcsj.62.2102
点击查看最新优质反应信息

文献信息

  • A simple and direct method for converting thioamides into thioesters
    作者:David C Harrowven、Matthew C Lucas、Peter D Howes
    DOI:10.1016/s0040-4020(98)01096-5
    日期:1999.1
    Thioamides may be transformed into thioesters through the simple expedient of warming them in an aqueous THF solution containing an alkylating agent. Reactions proceed in high yield and are amenable to multi-gram scale.
    通过在含有烷基化剂的THF水溶液中加热它们的简单简便方法,可将硫酰胺转化为硫酯。反应以高收率进行,并且适合多克规模。
  • Stereocontrolled Synthesis of Adjacent Acyclic Quaternary-Tertiary Motifs: Application to a Concise Total Synthesis of (−)-Filiformin
    作者:Daniel J. Blair、Catherine J. Fletcher、Katherine M. P. Wheelhouse、Varinder K. Aggarwal
    DOI:10.1002/anie.201400944
    日期:2014.5.26
    developed for the synthesis of acyclic quaternary‐tertiary motifs with full control of relative and absolute stereochemistry, thus leading to all four possible isomers of a stereodiad. A novel intramolecular Zweifel‐type olefination enabled acyclic stereocontrol to be transformed into cyclic stereocontrol. These key steps have been applied to the shortest enantioselective synthesis of (−)‐filiformin
    已经开发了锂化/硼氢化方法学,用于合成无环四级-三级基序,并且可以完全控制相对和绝对立体化学,因此可以生成立体二价体的所有四种可能的异构体。新型的分子内Zweifel型烯化反应使无环立体控制转变为环立体控制。迄今为止,这些关键步骤已应用于具有完全立体控制的最短对映选择性合成(-)-filiformin(9个步骤)。
  • [EN] THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS<br/>[FR] DÉRIVÉS DE THÉNOPYRIDONE COMME ACTIVATEURS DE LA PROTÉINE KINASE DÉPENDANTE DE L'AMP (AMPK)
    申请人:MERCK PATENT GMBH
    公开号:WO2009124636A1
    公开(公告)日:2009-10-15
    The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in claim 1, including pharmaceutical compositions thereof and for their use in the treatment and/or prevention of diseases and disorders modulated by AMP agonists. The invention is also directed to intermediates and to a method of preparation of compounds of formula (I).
    本发明涉及式(I)的化合物,其中R1、R2和R3如权利要求1所定义,包括其药物组合物以及用于治疗和/或预防由AMP激动剂调节的疾病和紊乱的用途。该发明还涉及中间体和式(I)化合物的制备方法。
  • THIENOPYRIDONE DERIVATIVES AS AMP-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATORS
    申请人:Cravo Daniel
    公开号:US20110034505A1
    公开(公告)日:2011-02-10
    The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in claim 1 , including pharmaceutical compositions thereof and for their use in the treatment and/or prevention of diseases and disorders modulated by AMP agonists. The invention is also directed to intermediates and to a method of preparation of compounds of formula (I).
    本发明涉及式(I)化合物,其中R1、R2和R3如权利要求1所定义,包括其药物组合物以及用于治疗和/或预防由AMP激动剂调节的疾病和紊乱的用途。该发明还涉及中间体和式(I)化合物的制备方法。
  • [EN] PYRIMIDINE, PYRIDINE AND TRIAZINE DERIVATIVES AS MAXI-K CHANNEL OPENERS.<br/>[FR] DÉRIVÉS DE PYRIMIDINE, PYRIDINE ET TRIAZINE EN TANT QU'OUVREURS DE CANAUX MAXI-K
    申请人:MITSUBISHI TANABE PHARMA CORP
    公开号:WO2009125870A1
    公开(公告)日:2009-10-15
    A compound of formula (A); wherein ring A is an aromatic ring or a heteroaromatic ring; R1 is independently halogen, cyano, etc., each of X1, X2 and X3 is CR2 or nitrogen, R2 is independently hydrogen, etc., n is 0, 1, 2, 3 or 4; -D-Y is -O-CH2COOH, etc, and G is a substituted amino, a substituted heterocyclic group, etc, or a pharmaceutical acceptable salt thereof, has activities of opening BK channels.
    化合物的结构式(A);其中环A是芳香环或杂芳环;R1独立地是卤素、氰基等;X1、X2和X3中的每一个是CR2或氮,R2独立地是氢等;n为0、1、2、3或4;-D-Y是-O-CH2COOH等;G是取代氨基、取代杂环基等,或其药用可接受盐,具有开放BK通道的活性。
查看更多